Anti-Cancer Agents in Medicinal Chemistry

(Formerly Current Medicinal Chemistry - Anti-Cancer Agents)


Simone Carradori
Department of Pharmacy
“G. d’Annunzio” University of Chieti-Pescara

Personal Subscription
Become EABM
Become Reviewer
Call for Editor

Development of Non-Coding RNAs as Biomarkers in Tumors of Digestive System promotion: free to download

Volume:19   Issue: 2
Pp: 143-144
Zhihua Xu* and Qiaoming Zhi*
DOI: 10.2174/187152061902190418104708
Published on: 30 May, 2019

Meet Our Editorial Board Member free to download

Volume:19   Issue: 2
Pp: 145-145
John Chirgwin
DOI: 10.2174/187152061902190418104851
Published on: 30 May, 2019

Multiple Perspectives in Anti-cancer Drug Discovery: From old Targets and Natural Products to Innovative Computational Approaches free to download

Volume:19   Issue: 2
Pp: 146-147
Alejandro Speck-Planche
DOI: 10.2174/187152061902190418105054
Published on: 30 May, 2019

Virtual Screening of Anti-Cancer Compounds: Application of Monte Carlo Technique

Volume:19   Issue: 2
Pp: 148-153
Alla P. Toropova*, Andrey A. Toropov, Emilio Benfenati, Danuta Leszczynska and Jerzy Leszczynski
DOI: 10.2174/1871520618666181025122318
Published on: 30 May, 2019

Virtual Screening of Natural Products to Select Compounds with Potential Anticancer Activity

Volume:19   Issue: 2
Pp: 154-171
Élida B.V.S. Cavalcanti, Mayara B. Félix, Luciana Scotti and Marcus T. Scotti*
DOI: 10.2174/1871520618666181119110934
Published on: 30 May, 2019

Phytochemicals in Anticancer Drug Development

Volume:19   Issue: 2
Pp: 172-183
Rohit Dutt, Vandana Garg, Naveen Khatri and Anil K. Madan*
DOI: 10.2174/1871520618666181106115802
Published on: 30 May, 2019

Hydroxyl Group Difference between Anthraquinone Derivatives Regulate Different Cell Death Pathways via Nucleo-Cytoplasmic Shuttling of p53

Volume:19   Issue: 2
Pp: 184-193
Mohd Kamil, Ejazul Haque, Snober S. Mir*, Safia Irfan, Adria Hasan, Saba Sheikh, Shamshad Alam, Kausar M. Ansari and Aamir Nazir
DOI: 10.2174/1871520618666181029133041
Published on: 30 May, 2019

What Makes Species Productive of Anti-Cancer Drugs? Clues from Drugs’ Species Origin, Druglikeness, Target and Pathway

Volume:19   Issue: 2
Pp: 194-203
Xiaofeng Li, Xiaoxu Li, Yinghong Li, Chunyan Yu, Weiwei Xue, Jie Hu*, Bo Li, Panpan Wang and Feng Zhu*
DOI: 10.2174/1871520618666181029132017
Published on: 30 May, 2019

Immunotherapeutic Approaches in Cancer Treatment free to download

Volume:19   Issue: 2
Pp: 204-205
Lihong Zhao, Lili Zhong, Songbai Xu and Bingjin Li*
DOI: 10.2174/187152061902190418105255
Published on: 30 May, 2019

Poly (ADP-Ribose) Polymerases (PARPs) and PARP Inhibitor-Targeted Therapeutics

Volume:19   Issue: 2
Pp: 206-212
Nan Li*, Yifan Wang, Weiye Deng and Steven H. Lin*
DOI: 10.2174/1871520618666181109164645
Published on: 30 May, 2019

New Strategies for Therapeutic Cancer Vaccines open access plus

Volume:19   Issue: 2
Pp: 213-221
Hanjiao Qin, Jiyao Sheng, Dan Zhang, Xuewen Zhang, Linlin Liu*, Bingjin Li*, Guangquan Li* and Zhuo Zhang
DOI: 10.2174/1871520618666181109151835
Published on: 30 May, 2019

Can Combined Therapy Benefit Immune Checkpoint Blockade Response in Hepatocellular Carcinoma?

Volume:19   Issue: 2
Pp: 222-228
Fan Zhongqi, Sun Xiaodong, Chen Yuguo and Lv Guoyue*
DOI: 10.2174/1871520618666181114112431
Published on: 30 May, 2019

Phage Display Technology and its Applications in Cancer Immunotherapy

Volume:19   Issue: 2
Pp: 229-235
Yicun Wang, Shuohui Gao, Jiayin Lv, Yang Lin*, Li Zhou and Liying Han
DOI: 10.2174/1871520618666181029140814
Published on: 30 May, 2019

Elevated Expression of A-Raf and FA2H in Hepatocellular Carcinoma is Associated with Lipid Metabolism Dysregulation and Cancer Progression

Volume:19   Issue: 2
Pp: 236-247
Maryam Ranjpour, Saima Wajid and Swatantra K. Jain*
DOI: 10.2174/1871520618666181015142810
Published on: 30 May, 2019

Cyclosporine A Suppresses the Malignant Progression of Oral Squamous Cell Carcinoma in vitro

Volume:19   Issue: 2
Pp: 248-255
Ling Gao*, Jianwei Dong, Nanyang Zhang, Zhanxian Le, Wenhao Ren*, Shaoming Li, Fan Li, Jianzhong Song, Qibo Wang, Zhichao Dou, Soo Y. Park and Keqian Zhi*
DOI: 10.2174/1871520618666181029170605
Published on: 30 May, 2019

Design, Synthesis, and Preliminary Bioactivity Evaluation of 2,7-Substituted Carbazole Derivatives as Potent Autotaxin Inhibitors and Antitumor Agents†

Volume:19   Issue: 2
Pp: 256-264
Wenming Wang, Fengmei Zhao, Yarui Zhao, Weiwei Pan, Pengcheng Cao, Lintao Wu, Zhijun Wang, Xuan Zhao, Yi Zhao* and Hongfei Wang*
DOI: 10.2174/1871520618666180830161821
Published on: 30 May, 2019

Design, Synthesis, In vitro Cytotoxic Activity Evaluation, and Study of Apoptosis Inducing Effect of New Styrylimidazo[1,2-a]Pyridines as Potent Anti-Breast Cancer Agents

Volume:19   Issue: 2
Pp: 265-275
Faeze Khalili, Sara Akrami, Malihe Safavi, Maryam Mohammadi-Khanaposhtani, Mina Saeedi, Sussan K. Ardestani, Bagher Larijani, Afsaneh Zonouzi*, Maliheh B. Tehrani* and Mohammad Mahdavi*
DOI: 10.2174/1871520618666180903100835
Published on: 30 May, 2019

Synthesis and Investigation of the Role of Benzopyran Dihydropyrimidinone Hybrids in Cell Proliferation, Migration and Tumor Growth

Volume:19   Issue: 2
Pp: 276-288
Ashutosh K. Dash, Debasis Nayak, Nazar Hussain, Mubashir J. Mintoo, Sumera Bano, Archana Katoch, Dilip M. Mondhe, Anindya Goswami* and Debaraj Mukherjee*
DOI: 10.2174/1871520618666180903101422
Published on: 30 May, 2019